792844

Kowa Pharmaceuticals America — FEI 3007640042

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 26, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Montgomery, AL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)